NXTC
NXTC
NASDAQ · Biotechnology

Nextcure Inc

$10.01
-0.12 (-1.18%)
As of Mar 29, 10:51 PM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +252.1% upside
Low Target $27.20
Average Target $35.25
High Target $53.45
Current Price $10.01
Current
$10.01
Target
$35.25
$27.20 $35.25 avg $53.45
Scenario Analysis
Bear Case
$27.20
171.7%
Low target
Base Case
$35.25
+252.1%
Avg target
Bull Case
$53.45
+434.0%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$15.74
-36.4% from high
52-Week Low
$2.69
+272.1% from low
Target vs 52W High
$35.25
+124.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%